Mycophenolic Acid

mechanistic target of rapamycin kinase ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35571122 Effect of Combined Mycophenolate and Rapamycin Treatment on Kidney Fibrosis in Murine Lupus Nephritis. 2022 1
2 32732827 Can Mammalian Target of Rapamycin Inhibitors Replace Mycophenolate in Hypersensitized Kidney Transplant Recipients? 2020 Aug 1
3 31377099 Evidence-based practice: Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patients. 2019 Oct 4
4 31385180 Outcomes of sirolimus regimens in 65-year-old and older kidney transplant recipients: a registry-based observational study. 2019 Nov 2
5 29130236 [Occurrence, diagnosis and treatment of de novo gastrointestinal malignancies after organ transplantation]. 2017 Oct 25 1
6 26126806 mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis. 2015 Jul 1 1
7 23740036 mTOR inhibitors in pediatric kidney transplantation. 2014 Jul 1
8 23414365 Correlations with six-month protocol biopsy findings in pediatric transplant recipients on low- and regular-dose CNI regimens. 2013 Mar-Apr 1
9 22664000 New immunosuppressive therapies and surgical complications after renal transplantation. 2012 Jun 2
10 23013949 mTOR inhibitor monotherapy. A good treatment choice in renal transplantation? 2012 1
11 21342445 Mycophenolic acid-mediated suppression of human CD4+ T cells: more than mere guanine nucleotide deprivation. 2011 Mar 1
12 21451536 Can the nephron be spared? 2011 Apr 1
13 21094806 Low-dose calcineurin inhibitor regimen combined with mammalian target of rapamycin inhibitors preserves kidney functions in renal transplant recipients without allograft nephropathy. 2010 Nov 2